Recent effect of fluoxetine in improving neurologic impairment and preventing post-stroke depression in the early stage

Chinese Journal of Clinical Rehabilitation

Volumn 8, Issue 7, 2004, Pages 1208-1209

  Li, Jing ^a   He, Qiu Yue ^a   Han, Man Fu ^a  

^a SECOND PEOPLE S HOSPITAL OF SHENZHEN   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ACUTE DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; HUMAN; NEUROLOGIC DISEASE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; STROKE;

EID: 2442597918     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Boyeson MG. Effects of fluoxetine and maprotiline on functional recovery in post-stroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996; 27 (11): 2145-6
2. Narushima K, Kosier JT, Robinson RG. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 2002; 190(5): 296-303
3. Fruehwald S, Gatterbauer E, Rehak P, et al. Early fluoxetine treatment of post-stroke depression: a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 2003; 250(3): 347-5
4. Chinese source. 2002,6(15): 2296-7
5. Stamenkovic M, Schindler S, Kasper S. Therapy of post-stroke depression with fluoxetine, apilot project. Nervenarzt 1996; 67(1): 62-7
6. Chinese source. 2002,6(3): 366
7. Chinese source. 2003,7(3): 374-5
8. Narushima K, Robinson RG. The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression: is there a time-related therapeutic window? J Nerv Ment Dis 2003; 191(10): 645-52
9. Jorge RE, Robinson RG, Arndt S, et al. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003; 160(10): 1823-9